Adam Brufsky, Joseph A. Sparano, Sara M. Tolaney, VK Gadi, Jason Shafrin, Xinglei Chai, Fan Yang, Zheng-Yi Zhou, Vaidyanathan Ganapathy, Corinth Auld, Gary Mark Sopher, Emma Alexander, Vamsi Bollu, Louis P. Garrison. "Economic evaluation of work productivity gains associated with ribociclib (RIB) in hormone receptor–positive/human epidermal growth factor receptor 2–negative (HR+/HER2−) early breast cancer (EBC) in the United States.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.e23117